ABC TRANSPORTERS

By U. JOINI

1 ROLE OF P-GLYCOPROTEIN FOR RESISTANCE OF TUMORS TO ANTICANCER DRUGS: FROM BENCH TO BEDSIDE 2 CLINICAL RELEVANCE OF MULTIDRUG-RESISTANCE-PROTEINS (MRPS) FOR ANTICANCER DRUG RESISTANCE AND PROGNOSIS 3 ROLE OF BREAST CANCER RESISTANCE PROTEIN (BCRP, ABCG2) IN CANCER OUTCOMES AND DRUG RESISTANCE 4 A NEW STRATEGY OF ALA-PHOTODYNAMIC CANCER THERAPY: INHIBITION OF ABC TRANSPORTER ABCG2 5 ATP BINDING CASSETTE TRANSPORTERS IN CANCER STEM-LIKE CELLS 6 RADIOPHARMACEUTICALS FOR THE IMAGING OF ABC-TRANSPORTER-MEDIATED MULTIDRUG RESISTANCE IN CANCER 7 MODULATION OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE BY SYNTHETIC AND PHYTOCHEMICAL SMALL MOLECULES, MONOCLONAL ANTIBODIES, AND THERAPEUTIC NUCLEIC ACIDS 8 ABC TRANSPORTER MODULATORY DRUGS FROM MARINE SOURCES: A NEW APPROACH TO OVERCOME DRUG RESISTANCE IN CANCER CONTENTS 9 THE ROLE OF ABC MULTIDRUG TRANSPORTERS IN RESISTANCE TO TARGETED ANTICANCER KINASE INHIBITORS 10 NANOTECHNOLOGY TO COMBAT MULTIDRUG RESISTANCE IN CANCER 11 DRUGS AFFECTING EPIGENETIC MODIFICATIONS OF ABC TRANSPORTERS FOR DRUG RESISTANCE